Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HDV-Insulin Lispro vs Insulin Lispro in Type 1 Diabetes
NCT06238778Phase 2Completed
- Sponsor
- Diasome Pharmaceuticals
- Start
- Dec 2023
- Primary completion
- Oct 2025
- Modality
- rProtein (Recombinant Protein), Biologic
- Countries
- 1
01
Overview
A Phase 2 trial of HDV-Insulin Lispro in type 1 diabetes mellitus (T1D), sponsored by Diasome Pharmaceuticals. Started Dec 2023; status: completed.
02
Drugs
HDV-Insulin Lispro
03
Conditions
type 1 diabetes mellitus (T1D)
Beyond the preview
Go deeper on NCT06238778.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06238778.